-
Evolution of Health Technology Assessment (HTA) in India: A Scoping Review and Thematic Analysis
Sep 9, 2025, 16:22 PM -
Societal and Economic Impact of Targeted Therapy for Breast Cancer in Bulgaria
Sep 9, 2025, 16:22 PM -
Care of Patients With Phenylketonuria (PKU) in Germany a Claims Data Analysis From 2013 to 2023
Sep 9, 2025, 16:22 PM -
The Development of the Multicriteria Decision Analysis in Specialized Burn Care: The Methodological Process
Sep 9, 2025, 16:22 PM -
Modeling the Lifetime Effects of Lecanemab in Early Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Understanding Treatment Preference Heterogeneity in Psoriasis: Insights From a Qualitative Analysis of Social Media Data
Sep 9, 2025, 16:22 PM -
Balancing Cost-Effectiveness With Societal Values: A Representative Survey of Norwegian Attitudes Toward Healthcare Resource Allocation
Sep 9, 2025, 16:22 PM -
Effectiveness of Subcutaneous Natalizumab in Multiple Sclerosis: Real-World Evidence From a Finnish Registry Study
Sep 9, 2025, 16:22 PM -
extRpolateS: A Shiny-Based Interactive Platform for Time-to-Event Data Modeling in Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Impact of Nontransfusion-Dependent Thalassemia on Adult Patients' Health-Related Quality of Life and Work Productivity in the Kingdom of Saudi Arabia and United Arab Emirates
Sep 9, 2025, 16:22 PM -
Patient Preferences in Gene Therapy Development for Arrhythmogenic Cardiomyopathy: The UR-HEART Qualitative Study
Sep 9, 2025, 16:22 PM -
Drivers of Improvement in Observed Survival in Malignant Cancer Sites: A Cancer Registry Analysis
Sep 9, 2025, 16:22 PM -
The Economic Burden of Amyotrophic Lateral Sclerosis: An Observational Study of Out-of-Pocket Expenses and the Impact on Caregivers
Sep 9, 2025, 16:22 PM -
What Generalized Cost-Effectiveness Analysis (GCEA) Reveals About the Applicability of Foreign Reference Pricing in Medicare Price Negotiation in the US
Sep 9, 2025, 16:22 PM -
Semaglutide Weight Outcomes Among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Real-World Setting
Sep 9, 2025, 16:22 PM -
The Economic Burden of Overweight and Obesity in Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Smartphone-Based Screening for Obstructive Sleep Apnea: A Markov Model Analysis From the German Statutory Health Insurance Perspective
Sep 9, 2025, 16:22 PM -
Real Option Value of Sotatercept in Pulmonary Arterial Hypertension: A Health Economic Perspective on Future Treatment Opportunities
Sep 9, 2025, 16:22 PM -
Evaluating the Budget Impact of Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) in Patients With Moderate to Severe Asthma in the Saudi Healthcare System
Sep 9, 2025, 16:22 PM -
Feasibility Assessment of a Real-World Comparator Cohort Using Multiple Qualifying Index Lines of Therapy (LOTs) in Third-Line or Later (3L+) Diffuse Large B-cell Lymphoma (DLBCL)
Sep 9, 2025, 16:22 PM
